Evaluating the efficacy of Glucantime and determinants of treatment success in cutaneous leishmaniasis: A retrospective study
{{output}}
Background: Cutaneous leishmaniasis (CL) is a major public health issue in endemic regions such as Shiraz, Iran. Glucantime (meglumine antimoniate), a pentavalent antimonial remains the first-line treatment. However, its efficacy... ...
